Stay updated on Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Sign up to get notified when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.

Latest updates to the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check23 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.9%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check52 days agoChange DetectedThe study has been withdrawn and will no longer proceed due to disapproval by the internal scientific review committee. The previously mentioned recruitment date has also been removed.SummaryDifference4%
Stay in the know with updates to Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.